Abstract:Exploring the molecular mechanisms of breast cancer is essential for the early prediction, diagnosis, and treatment of cancer patients. The large scale of data obtained from the high-throughput sequencing technology makes it difficult to identify the driver mutations and a minimal optimal set of genes that are critical to the classification of cancer. In this study, we propose a novel method without any prior information to identify mutated genes associated with breast cancer. For the somatic mutation data, it is processed to a mutated matrix, from which the mutation frequency of each gene can be obtained. By setting a reasonable threshold for the mutation frequency, a mutated gene set is filtered from the mutated matrix. For the gene expression data, it is used to generate the gene expression matrix, while the mutated gene set is mapped onto the matrix to construct a co-expression profile. In the stage of feature selection, we propose a staged feature selection algorithm, using fold change, false discovery rate to select differentially expressed genes, mutual information to remove the irrelevant and redundant features, and the embedded method based on gradient boosting decision tree with Bayesian optimization to obtain an optimal model. In the stage of evaluation, we propose a weighted metric to modify the traditional accuracy to solve the sample imbalance problem. We apply the proposed method to The Cancer Genome Atlas breast cancer data and identify a mutated gene set, among which the implicated genes are oncogenes or tumor suppressors previously reported to be associated with carcinogenesis. As a comparison with the integrative network, we also perform the optimal model on the individual gene expression and the gold standard PMA50. The results show that the integrative network outperforms the gene expression and PMA50 in the average of most metrics, which indicate the effectiveness of our proposed method by integrating multiple data sources, and can discover the associated mutated genes in breast cancer.

An Efficient Gene Selection Technique for Cancer Recognition Based on Neighborhood Mutual Information.

Neighborhood Rough Set Reduction-Based Gene Selection and Prioritization for Gene Expression Profile Analysis and Molecular Cancer Classification.

A Cancer Gene Selection Algorithm Based on the K-S Test and CFS

A Co-Expression Modules Based Gene Selection for Cancer Recognition.

Multiclass Cancer Classification by Using Fuzzy Support Vector Machine and Binary Decision Tree with Gene Selection

An Ensemble Correlation-Based Gene Selection Algorithm for Cancer Classification with Gene Expression Data

A method for informative gene selection using neighborhood uncertainty and scoring criteria

Gene selection for cancer classification using a hybrid of univariate and multivariate feature selection methods

Gene selection and cancer classification using Monte Carlo and nonnegative matrix factorization

Gene Selection for Cancer Classification using Support Vector Machines

Cancer Relevant Genes Selection Approach from Integrated Information

An Integrated Feature Selection Algorithm for Cancer Classification using Gene Expression Data.

Feature Selection for Breast Cancer Classification by Integrating Somatic Mutation and Gene Expression.

Identification of Gene Expression in Different Stages of Breast Cancer with Machine Learning

Gene Selection for Tumor Classification Using Neighborhood Rough Sets and Entropy Measures

Joint Neighborhood Entropy-Based Gene Selection Method with Fisher Score for Tumor Classification

Gene selection and classification for cancer microarray data based on machine learning and similarity measures

Gene Selection Method Based on Neighborhood Rough Sets and Fish Swarm Intelligence

Gene Selection and Cancer Classification: A Rough Sets Based Approach.

MGRFE: Multilayer Recursive Feature Elimination Based on an Embedded Genetic Algorithm for Cancer Classification

Feature Selection and Classification of MAQC-II Breast Cancer and Multiple Myeloma Microarray Gene Expression Data